Literature DB >> 19545851

Empirical fitting of soft or rigid gas-permeable contact lenses for the correction of moderate to severe refractive astigmatism: a comparative study.

Langis Michaud1, Cynthia Barriault, Annie Dionne, Peter Karwatsky.   

Abstract

BACKGROUND: This study aims to validate the fitting of contact lenses derived from refractive and keratometric values in a group of subjects with moderate (2.50 diopters [D] to 5.00 D) to severe (>5.00 D) astigmatism. It aims also to show whether soft or rigid gas-permeable (GP) contact lenses offer the best correction and to determine which modality is preferred by subjects.
METHODS: Twenty subjects were randomly fitted with both soft and GP lenses. Group A was first fitted with soft lenses then switched to GPs and vice versa for group B. For each type of lens worn, low- and high-contrast visual acuity (VA) and stereoscopy were evaluated at both near and far. Each subject was asked to select the lens type of choice and to rate quality of vision in day-to-day activities through a questionnaire.
RESULTS: There was no significant difference in objective binocular VA between current spectacles and empirically calculated soft toric lenses and GP toric/bi-toric contact lenses at all distances. That was also true for stereoscopy. Subjectively, most of the subjects preferred rigid contact lenses because of the quality of their vision in day-to-day activities, and a majority of them decided to continue with that modality.
CONCLUSION: Empirical fitting of toric soft or GP contact lenses leads to very good results, which suggests that each type of lens might constitute a viable option.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545851     DOI: 10.1016/j.optm.2008.11.008

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  1 in total

1.  AcrySof toric intraocular lens for post-keratoplasty astigmatism.

Authors:  Nishant Gupta; Jagat Ram; Manish Chaudhary
Journal:  Indian J Ophthalmol       Date:  2012 May-Jun       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.